Position in LXEO
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$73,770
-$72,717 QoQ
Shares Held
12,852
-12.9% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LXEO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026ProShare Advisors LLC holds $466,686,133 across 164 Biotechnology names. LXEO ranks #140 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
373,532 | $166,796,979 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
152,397 | $117,748,018 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
174,013 | $57,575,681 | |
| 4 | INSM |
INSMED Inc
|
283,141 | $46,299,216 | |
| 5 | INCY |
Incyte Corp
|
49,678 | $4,675,693 | |
| 6 | MRNA |
Moderna, Inc.
|
71,342 | $3,624,173 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
31,677 | $2,352,334 | |
| 8 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
31,498 | $1,974,924 |
All Filings in LXEO
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $73,770 | 12,852 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $146,487 | 14,752 | Shares | Sole | 2026-02-06 | |
| No filing history on record for this holder in this stock. | ||||||